In this video, Ruben Mesa, MD, executive director of the Mays Cancer, discusses the rationale for the earlier use of ruxolitinib (Jakafi) in myelofibrosis.
In this video, Ruben Mesa, MD, executive director of the Mays Cancer, discusses the rationale for the earlier use of ruxolitinib (Jakafi) in myelofibrosis.